{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:15:52Z","timestamp":1791350152644,"version":"4.3.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.neurol.2013.07.016","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T18:45:39Z","timestamp":1379097939000},"page":"744-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Alzheimer disease: From biomarkers to diagnosis"],"prefix":"10.1016","volume":"169","author":[{"given":"B.","family":"Dubois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Epelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Michon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sarazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"15","key":"10.1016\/j.neurol.2013.07.016_bib0010","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/01.wnl.0000277459.83543.99","article-title":"The significance of medial temporal lobe atrophy: a post-mortem MRI study in the very old","volume":"69","author":"Barkhof","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neurol.2013.07.016_bib0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2013.07.016_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000315542","article-title":"New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population","volume":"30","author":"Bouwman","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer's disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.neurol.2013.07.016_bib0035","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.neurobiolaging.2007.08.010","article-title":"Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment","volume":"30","author":"Brys","year":"2009","journal-title":"Neurobiol Aging"},{"issue":"Pt 11","key":"10.1016\/j.neurol.2013.07.016_bib0040","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated-tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.neurol.2013.07.016_bib0045","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archneurol.2009.279","article-title":"Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report","volume":"66","author":"Cairns","year":"2009","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2013.07.016_bib0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jalz.2012.10.006","article-title":"Research and standardization in Alzheimer's trials: reaching international consensus","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S1041610207004838","article-title":"Relevance of outcome measures in different cultural groups--does one size fit all?","volume":"19","author":"Chiu","year":"2007","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0060","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.neurol.2013.07.016_bib0065","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/gps.2448","article-title":"Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis","volume":"25","author":"de Jager","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"issue":"19","key":"10.1016\/j.neurol.2013.07.016_bib0070","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","article-title":"Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose\/poitron-emission tomography (FDG\/PET)","volume":"98","author":"de Leon","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.2010.207183","article-title":"Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias","volume":"82","author":"de Souza","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/15622970701535502","article-title":"Do CSF total tau, phosphorylated-tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature","volume":"9","author":"Diniz","year":"2008","journal-title":"World J Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.neurol.2013.07.016_bib0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2013.07.016_bib0090","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","article-title":"Revising the definition of Alzheimer's disease: a new lexicon","volume":"9","author":"Dubois","year":"2010","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0095","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid A\u03b242 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann Neurol"},{"issue":"8\u20139","key":"10.1016\/j.neurol.2013.07.016_bib0100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol Med"},{"issue":"9","key":"10.1016\/j.neurol.2013.07.016_bib0105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archneurol.2011.105","article-title":"Comparison of analytical platforms for cerebrospinal fluid measures of beta-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology","volume":"68","author":"Fagan","year":"2011","journal-title":"Arch Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2013.07.016_bib0110","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","article-title":"PET imaging of amyloid deposition in patients with mild cognitive impairment","volume":"29","author":"Forsberg","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.neurol.2013.07.016_bib0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrneurol.2012.27","article-title":"Modifiable factors that alter the size of the hippocampus with ageing","volume":"8","author":"Fotuhi","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"10.1016\/j.neurol.2013.07.016_bib0120","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00415-010-5650-0","article-title":"The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment","volume":"257","author":"Galluzzi","year":"2010","journal-title":"J Neurol"},{"issue":"Pt\u00a03","key":"10.1016\/j.neurol.2013.07.016_bib0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/brain\/123.3.484","article-title":"Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuro-imaging and pathological study of 13 cases","volume":"123","author":"Galton","year":"2000","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurol.2013.07.016_bib0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0925-4927(95)02593-M","article-title":"Reliability of cerebral measures in repeated examinations with magnetic resonance imaging","volume":"61","author":"Giedd","year":"1995","journal-title":"Psychiatry Res"},{"issue":"11","key":"10.1016\/j.neurol.2013.07.016_bib0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2009.01.027","article-title":"Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid","volume":"65","author":"Grimmer","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2013.07.016_bib0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1468-1331.2009.02753.x","article-title":"Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe","volume":"17","author":"Hort","year":"2010","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0150","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00401-012-0943-2","article-title":"Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study","volume":"123","author":"Ikonomovic","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.neurol.2013.07.016_bib0155","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1602\/neurorx.1.2.226","article-title":"Biomarkers of Alzheimer disease in plasma","volume":"1","author":"Irizarry","year":"2004","journal-title":"NeuroRx"},{"issue":"4","key":"10.1016\/j.neurol.2013.07.016_bib0160","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer's Disease Neuro-imaging Initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J Magn Reson Imaging"},{"issue":"15","key":"10.1016\/j.neurol.2013.07.016_bib0165","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","article-title":"Relationships between biomarkers in aging and dementia","volume":"73","author":"Jagust","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2013.07.016_bib0170","doi-asserted-by":"crossref","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","article-title":"Brain imaging in Alzheimer disease","volume":"2","author":"Johnson","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neurol.2013.07.016_bib0175","article-title":"Effects of APOE epsilon4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment","author":"Kim","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"12","key":"10.1016\/j.neurol.2013.07.016_bib0180","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/WNL.0b013e318212015e","article-title":"Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study","volume":"76","author":"Koivunen","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0185","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.0b013e3181e8e8b8","article-title":"Comparing predictors of conversion and decline in mild cognitive impairment","volume":"75","author":"Landau","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurol.2013.07.016_bib0190","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1373\/clinchem.2005.058776","article-title":"Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid beta peptides","volume":"52","author":"Lewczuk","year":"2006","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.neurol.2013.07.016_bib0195","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/01.wnl.0000267428.62582.aa","article-title":"CSF tau\/A\u03b242 ratio for increased risk of mild cognitive impairment: a follow-up study","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neurol.2013.07.016_bib0200","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/archneurol.2011.123","article-title":"Longitudinal change of biomarkers in cognitive decline","volume":"68","author":"Lo","year":"2011","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2013.07.016_bib0205","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"Mattsson","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.neurol.2013.07.016_bib0210","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.neurol.2013.07.016_bib0215","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.neurol.2013.07.016_bib0225","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archneurol.2009.269","article-title":"Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease","volume":"66","author":"Morris","year":"2009","journal-title":"Arch Neurol"},{"issue":"10","key":"10.1016\/j.neurol.2013.07.016_bib0230","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurol.2013.07.016_bib0235","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00259-012-2102-3","article-title":"Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG-PET","volume":"39","author":"Ossenkoppele","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.neurol.2013.07.016_bib0240","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/gps.2696","article-title":"Applying the new research diagnostic criteria: MRI findings and neuropsychological correlations of prodromal AD","volume":"27","author":"Rami","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"issue":"19","key":"10.1016\/j.neurol.2013.07.016_bib0245","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1212\/01.wnl.0000279336.36610.f7","article-title":"Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study","volume":"69","author":"Sarazin","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurol.2013.07.016_bib0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","article-title":"Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort","volume":"78","author":"Schoonenboom","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2013.07.016_bib0255","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuro-imaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.neurol.2013.07.016_bib0260","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archneurol.2009.55","article-title":"Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer-type","volume":"66","author":"Snider","year":"2009","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0265","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.neurol.2013.07.016_bib0270","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF A\u03b2 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2013.07.016_bib0275","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2013.07.016_bib0280","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2967\/jnumed.109.064360","article-title":"Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding","volume":"50","author":"Tolboom","year":"2009","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.neurol.2013.07.016_bib0285","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/jnnp.2008.158881","article-title":"White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study","volume":"80","author":"van de Pol","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.neurol.2013.07.016_bib0290","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1258\/acb.2009.008232","article-title":"A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease","volume":"46","author":"Verwey","year":"2009","journal-title":"Ann Clin Biochem"},{"issue":"7","key":"10.1016\/j.neurol.2013.07.016_bib0295","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1474-4422(09)70139-5","article-title":"Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study","volume":"8","author":"Visser","year":"2009","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.neurol.2013.07.016_bib0300","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.0b013e318245f447","article-title":"Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease","volume":"78","author":"Wagner","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neurol.2013.07.016_bib0305","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/archneurol.2011.153","article-title":"Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology","volume":"68","author":"Wolk","year":"2011","journal-title":"Arch Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378713008758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378713008758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T03:05:40Z","timestamp":1563937540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378713008758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":61,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0035378713008758"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2013.07.016","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer disease: From biomarkers to diagnosis","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2013.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}